<DOC>
	<DOCNO>NCT00614757</DOCNO>
	<brief_summary>The purpose study evaluate often patient hepatitis C infection abnormality sugar fat utilization . Additionally would like find abnormality sugar fat utilization common liver disease , relate overweight .</brief_summary>
	<brief_title>Insulin Resistance Study</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Ability give write consent HCV RNA PCR positive 6 month Normal Hgb , WBC , Neutrophils Platelets &gt; /= 65,000 Direct Bili , within 20 % ULN Albumin &gt; 3 Serum Creatinine &lt; 20 % ULN TSH WNL AFP &lt; /= 100 Women pregnant breastfeed No Thiazolidinedione , Metformin , unless require treatment type II DM Hepatitis C nongenotype 1,2,3 Any cause liver disease chronic hepatitis C Hemoglobinopathies Evidence advance liver disease Previous organ transplant Severe psychiatric disorder Significant cardiovascular dysfunction within past 12 month Poorly control diabetes mellitus Immunologically mediated disease Any medical condition require chronic systemic administration steroid Evidence active suspect cancer Substance abuse time study Known HIV Irritability unwillingness provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>